The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

British Journal of Cancer ◽

10.1038/bjc.2017.119 ◽

2017 ◽

Vol 116 (11) ◽

pp. 1402-1407 ◽

Author(s):

Rachna T Shroff ◽

Mark Yarchoan ◽

Ashley O'Connor ◽

Denise Gallagher ◽

Marianna L Zahurak ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Mek Inhibitor ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

Erratum: The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma

British Journal of Cancer ◽

10.1038/bjc.2017.418 ◽

2018 ◽

Vol 118 (2) ◽

pp. e2-e2 ◽

Author(s):

Rachna T Shroff ◽

Mark Yarchoan ◽

Ashley O'Connor ◽

Denise Gallagher ◽

Marianna L Zahurak ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Mek Inhibitor ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

172 Preclinical profile of ABP309, a potent 2nd generation VEGF receptor tyrosine kinase inhibitor belonging to the class of aminonicotinamides

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)80180-0 ◽

2004 ◽

Vol 2 (8) ◽

pp. 54-55

Author(s):

J. Brueggen ◽

G. Bold ◽

R. Cozens ◽

P.W. Manley ◽

J. Mestan ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Download Full-text

Abstract 3270: Combination strategy to circumvent the acquired resistance to VEGF receptor tyrosine kinase inhibitor in M24met melanoma in mice

10.1158/1538-7445.am2011-3270 ◽

2011 ◽

Author(s):

Lianglin Zhang ◽

Maruja E. Lira ◽

Keith A. Ching ◽

Enhong Chen ◽

Tina Lu ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Acquired Resistance ◽

Vegf Receptor ◽

Combination Strategy ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

Microdialysis measurement of intratumoral temozolomide concentration after cediranib, a pan-VEGF receptor tyrosine kinase inhibitor, in a U87 glioma model

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2172-3 ◽

2013 ◽

Vol 72 (1) ◽

pp. 93-100 ◽

Author(s):

Rachel Grossman ◽

Betty Tyler ◽

Michelle A. Rudek ◽

Eugene Kim ◽

Patti Zadnik ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Download Full-text

P-359 Results from a phase I study of the oral VEGF receptor tyrosine kinase inhibitor ZD6474, in patients with solid tumors

Lung Cancer ◽

10.1016/s0169-5002(03)92327-0 ◽

2003 ◽

Vol 41 ◽

pp. S182

Author(s):

Catherine Wheeler ◽

Hironobu Minami ◽

Hiromichi Ebi ◽

Makoto Tahara ◽

Yasutsuna Sasaki ◽

...

Keyword(s):

Tyrosine Kinase ◽

Phase I ◽

Tyrosine Kinase Inhibitor ◽

Solid Tumors ◽

Receptor Tyrosine Kinase ◽

Phase I Study ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

The Synergistic Action of a VEGF-Receptor Tyrosine-Kinase Inhibitor and a Sensitizing PDGF-Receptor Blocker Depends upon the Stage of Vascular Maturation

Microcirculation ◽

10.1080/10739680701370021 ◽

2007 ◽

Vol 14 (8) ◽

pp. 813-825 ◽

Author(s):

Ruslan Hlushchuk ◽

Oliver Baum ◽

Guenther Gruber ◽

Jeanette Wood ◽

Valentin Djonov

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Synergistic Action ◽

Receptor Blocker ◽

Vegf Receptor ◽

Pdgf Receptor ◽

Receptor Tyrosine Kinase Inhibitor ◽

Vascular Maturation

Download Full-text

A Phase Ib Study of the VEGF Receptor Tyrosine Kinase Inhibitor Tivozanib and Modified FOLFOX-6 in Patients With Advanced Gastrointestinal Malignancies

Clinical Colorectal Cancer ◽

10.1016/j.clcc.2014.12.001 ◽

2015 ◽

Vol 14 (1) ◽

pp. 18-24.e1 ◽

Author(s):

Corina N. Oldenhuis ◽

Walter J. Loos ◽

Brooke Esteves ◽

Leni van Doorn ◽

Monette M. Cotreau ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Gastrointestinal Malignancies ◽

Phase Ib ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

41 A potential for combining the rapamycin derivative RAD001 (everolimus) with the EGF/ErbB2/VEGF receptor tyrosine kinase inhibitor AEE788 in human cancer

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(04)80049-1 ◽

2004 ◽

Vol 2 (8) ◽

pp. 16 ◽

Author(s):

C. Stephan ◽

S. Zumstein-Mecker ◽

S. Gerboth ◽

A. Boulay ◽

S. Ruetz ◽

...

Keyword(s):

Tyrosine Kinase ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Human Cancer ◽

Vegf Receptor ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text

A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-1881 ◽

2019 ◽

Vol 25 (18) ◽

pp. 5475-5484 ◽

Author(s):

Razelle Kurzrock ◽

Douglas W. Ball ◽

Marianna L. Zahurak ◽

Barry D. Nelkin ◽

Vivek Subbiah ◽

...

Keyword(s):

Tyrosine Kinase ◽

Phase I ◽

Tyrosine Kinase Inhibitor ◽

Receptor Tyrosine Kinase ◽

Phase I Trial ◽

Kinase Inhibitor ◽

Mek Inhibitor ◽

Vegf Receptor ◽

Advanced Solid Tumors ◽

Differentiated Thyroid Cancers

Download Full-text

Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with irinotecan and capecitabine in patients with advanced solid tumors

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.2530 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 2530-2530 ◽

Author(s):

P. Witteveen ◽

M. Langenberg ◽

H. M. Verheul ◽

J. Roodhart ◽

M. Roelvink ◽

...

Keyword(s):

Tyrosine Kinase ◽

Phase I ◽

Tyrosine Kinase Inhibitor ◽

Solid Tumors ◽

Receptor Tyrosine Kinase ◽

Kinase Inhibitor ◽

Vegf Receptor ◽

Advanced Solid Tumors ◽

Receptor Tyrosine Kinase Inhibitor

Download Full-text